Cargando…

Modulation of c‐myc Expression by Transforming Growth Factor β1 in Human Hepatoma Cell Lines

The effects of transforming growth factor β1 (TGF‐β1) on cell proliferation of human hepatoma cell lines, PLC/PRF/5 and Mahlavu, were investigated under serum‐free conditions. DNA synthesis was strongly inhibited in the PLC/PRF/5 cells by addition of TGF‐β1 (0.5 to 4.0 ng/ml), but remained unchanged...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ito, Nobuyuki, Kawata, Sumio, Tamura, Shinji, Takaishi, Kenji, Saitoh, Ryuzo, Tarui, Seiichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1990
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918033/ https://www.ncbi.nlm.nih.gov/pubmed/2161812 http://dx.doi.org/10.1111/j.1349-7006.1990.tb02552.x

Ejemplares similares

Expression of Transforming Growth Factor‐β1 mRNA in Human Hepatocellular Carcinoma
por: Ito, Nobuyuki, et al.
Publicado: (1990)

Elevated Levels of Plasma Transforming Growth Factor‐β in Patients with Hepatocellular Carcinoma
por: Shirai, Yasuhiro, et al.
Publicado: (1992)

Effect of Pravastatin, a Potent 3‐Hydroxy‐3‐methylgliitaryl‐coenzyme A Reductase Inhibitor, on Survival of AH130 Hepatoma‐bearing Rats
por: Kawata, Sumio, et al.
Publicado: (1992)

Potentiation of Invasive Capacity of Rat Ascites Hepatoma Cells by Transforming Growth Factor‐β
por: Mukai, Mutsuko, et al.
Publicado: (1989)

Suppression of Human Pancreatic Cancer Growth in BALB/c Nude Mice by Manumycin, a Farnesyl:protein Transferase Inhibitor
por: Ito, Toshio, et al.
Publicado: (1996)

Coamplification of the L‐myc and N‐myc Oncogenes in a Neuroblastoma Cell Line
por: Jinbo, Takeshi, et al.
Publicado: (1989)

Overexpression of c‐Myc Inhibits the Appearance of a Specific DNase I Hypersensitive Site in the β‐Globin Chromatin in Murine Erythroleukemia Cells
por: Takada, Shinji, et al.
Publicado: (1991)

L‐myc Genotype is Associated with Different Susceptibility to Lung Cancer in Smokers
por: Kumimoto, Hiroshi, et al.
Publicado: (2002)

In vitro Invasion of Endothelial Cell Monolayer by Rat Ascites Hepatoma Cells
por: Ohigashi, Hiroaki, et al.
Publicado: (1989)

Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors
por: Li, Weiping, et al.
Publicado: (2019)

Metabolic changes in cancer cells upon suppression of MYC
por: Anso, Elena, et al.
Publicado: (2013)

AMPLIFIED ALLELE OF THE HUMAN N‐myc ONCOGENE IN NEUROBLASTOMAS
por: Yamada, Masao, et al.
Publicado: (1988)

Abnormal Copper Accumulation in Non‐cancerous and Cancerous Liver Tissues of LEC Rats Developing Hereditary Hepatitis and Spontaneous Hepatoma
por: Li, Yu, et al.
Publicado: (1991)

Differing Distribution of Hepatocyte Growth Factor‐positive Cells in the Liver of LEC Rats with Acute Hepatitis, Chronic Hepatitis and Hepatoma
por: Nakayama, Nobuaki, et al.
Publicado: (1995)

A Novel Tetracyclic Peptide, Trapoxin, Induces Phenotypic Change from Transformed to Normal in sis‐Oncogene‐transformed NIH3T3 Cells
por: Yoshida, Hiroshi, et al.
Publicado: (1992)

Detection of the c‐myc Gene Product in Urinary Bladder Cancer
por: Kotake, Toshihiko, et al.
Publicado: (1990)

Establishment of a Human Small Cell Lung Carcinoma Cell Line Carrying Amplification of c‐myc Gene and Chromosomal Translocation of t(3p;6p) and t(12q;17p)
por: Kato, Atsushi, et al.
Publicado: (1993)

NO CORRELATION BETWEEN L‐myc RESTRICTION FRAGMENT LENGTH POLYMORPHISM AND MALIGNANCY OF HUMAN COLORECTAL CANCERS
por: Ikeda, Isuzu, et al.
Publicado: (1988)

Point Mutation of the neu Gene in Rat Neural Tumor RT4‐AC Cells: Suppression of Tumorigenicity by s‐Myc
por: Lee, Soo‐Yong, et al.
Publicado: (1990)

Co‐amplification of c‐myc and c‐erbB‐2 Oncogenes in a Poorly Differentiated Human Gastric Cancer
por: Tsuchiya, Terumasa, et al.
Publicado: (1989)

Normal Human Chromosome 1 Carries Suppressor Activity for Various Phenotypes of a Kirsten Murine Sarcoma Virus‐transformed NIH/3T3 Cell Line
por: Yamada, Hideto, et al.
Publicado: (1990)

Correlation between Physiological and Transforming Activities of the c–mos Proto–oncogene Product and Identification of an Essential Mos Domain for These Activities
por: Okazaki, Kenji, et al.
Publicado: (1991)

Mutations and Reduced Expression of the Transforming Growth Factor‐β Receptor II Gene in Rat Lung Adenocarcinomas Induced by N‐Nitrosobis‐(2‐hydroxypropyl)amine
por: Tsujiuchi, Toshifumi, et al.
Publicado: (2000)

H‐ras p21 AND PEANUT LECTIN IMMUNOREACTIVITY OF HYPERPLASTIC, PRENEOPLASTIC AND NEOPLASTIC URINARY BLADDER LESIONS IN RATS
por: Ward, Jerrold M., et al.
Publicado: (1988)

PSMA expression in the Hi‐Myc model; extended utility of a representative model of prostate adenocarcinoma for biological insight and as a drug discovery tool
por: Simons, Brian W., et al.
Publicado: (2019)

Close Correlation between the Dephosphorylation of p53 and Growth Suppression by Transforming Growth Factor‐β1 in Nasopharyngeal Carcinoma Cells Transduced with Adenovirus Early Region Genes
por: Mogi, Yoshihiro, et al.
Publicado: (1994)

Effects of Sodium Nitrite and Catechol or 3‐Methoxycatechol in Combination on Rat Stomach Epithelium
por: Hirose, Masao, et al.
Publicado: (1990)

Modulation of the mevalonate pathway and cell growth by pravastatin and d-limonene in a human hepatoma cell line (Hep G2).
por: Kawata, S., et al.
Publicado: (1994)

Induction of Aberrant Crypt Foci in the Large Intestine of F344 Rats by Oral Administration of 2‐Amino‐l‐methyl‐6‐phenylimidazo[4,5‐b]pyridine
por: Takahashi, Satoru, et al.
Publicado: (1991)

Stabilization of MYC G-quadruplex DNA by ruthenium (II) complex overcomes imatinib resistance in chronic myeloid leukemia cells harboring T315I mutation
por: Sun, Yuening, et al.
Publicado: (2022)

A B‐CELL LINE HAVING CHROMOSOME 14 ABERRATION AT BREAK BAND qll DERIVED FROM AN ADULT T‐CELL LEUKEMIA PATIENT
por: Miyamoto, Kanji, et al.
Publicado: (1988)

Apoptotic Cytotoxic Effects of a Histone Deacetylase Inhibitor, FK228, on Malignant Lymphoid Cells
por: Murata, Makoto, et al.
Publicado: (2000)

Induction of Adenocarcinomas in the Glandular Stomach of BALB/c Mice Treated with N‐Methyl‐N‐nitrosourea
por: Tatematsu, Masae, et al.
Publicado: (1992)

Overexpression of Midkine in Pancreatic Duct Adenocarcinomas Induced by N‐Nitrosobis(2‐oxopropyl)amine in Hamsters and Their Cell Lines
por: Tsutsumi, Masahiro, et al.
Publicado: (2000)

Quantitative Measurement of Cell Motility Associated with Transformed Phenotype
por: Tatsuka, Masaaki, et al.
Publicado: (1989)

A novel microRNA miR-MTCO3P38 inhibits malignant progression via STAT3/PTTG1/MYC in hepatocellular carcinoma
por: Guo, Deliang, et al.
Publicado: (2021)

CD7 Expression in Malignant Pleural Mesothelioma
por: Hibi, Shigeyoshi, et al.
Publicado: (1992)

A NEW MEDIUM‐TERM BIOASSAY SYSTEM FOR DETECTION OF ENVIRONMENTAL CARCINOGENS USING DIETHYLNITROSAMINE‐INITIATED RAT LIVER FOLLOWED BY D‐GALACTOSAMINE TREATMENT AND PARTIAL HEPATECTOMY
por: Ito, Nobuyuki, et al.
Publicado: (1988)

Stomach Carcinogenicity of Caffeic Acid, Sesamol and Catechol in Rats and Mice
por: Hirose, Masao, et al.
Publicado: (1990)

A SYNTHETIC SINGLE‐STRANDED DNA, POLY(dG, dC), INDUCES TNTERFERON‐α/β AND ‐γ, AUGMENTS NATURAL KILLER ACTIVITY, AND SUPPRESSES TUMOR GROWTH
por: Tokunaga, Tohru, et al.
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_h8l4ko03mgm9oi5n34nispec8k